CDKN3 and carcinoma of esophagus: KIF4A-based multi-gene signatures, such as KIF4A + RAD51AP1 + CDKN3 in oesophageal cancer, are poised to enter clinical practice as routine tools for molecular diagnostics and prognostic predictions, enabling more precise patient stratification.